Health Catalyst Q3 revenue beats guidance, adjusted EBITDA loss improves 10%

Health Catalyst, Inc.

2021-Q3 EPS reported -$2.27 revenue$177,210,000

Total revenue $61.7 million (+31% YoY); technology revenue $38.3 million (+37%) and professional services $23.5 million (+22%).
GAAP net loss $40 million (vs $27.3 million loss in Q3 2020); operating loss $42.2 million (vs $23.5 million).
Adjusted EBITDA loss $(5.8) million improved 10% from $(6.4) million loss in prior-year quarter.
Adjusted technology gross margin 70% (up from 68%); total adjusted gross margin flat at 51%.
CEO Dan Burton noted strong Q3 performance, exceeding mid-point of guidance for both revenue and adjusted EBITDA.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.